These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 650206)

  • 1. Increased effect of apomorphine on homovanillic acid in rats terminated from chronic haloperidol.
    Smith RC; Narasimhachari N; Davis JM
    J Neural Transm; 1978; 42(2):159-62. PubMed ID: 650206
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Developmental change in striatal concentration of homovanillic acid and 3,4-dihydroxyphenylacetic acid in response to apomorphine and haloperidol treatment.
    Nomura Y; Komori T; Okuda S; Segawa T
    Arch Int Pharmacodyn Ther; 1979 Jan; 237(1):25-30. PubMed ID: 485682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Relationship of the homovanillic acid content in the rat brain after the administration of a neuroleptic and the degree of dopamine receptor sensitivity to an agonist].
    Zharkovskiĭ AM; Allikmets LKh; Otter MIa
    Biull Eksp Biol Med; 1979 Jun; 87(6):559-60. PubMed ID: 572714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of piribedil and one of its metabolites on the concentration of homovanillic acid in the rat brain.
    Jori A; Cecchetti G; Dolfini E; Monti E; Garattini S
    Eur J Pharmacol; 1974 Jul; 27(2):245-8. PubMed ID: 4851685
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of d- and 1-fenfluramine on striatal homovanillic acid concentrations in rats after pharmacological manipulation of brain serotonin.
    Crunelli V; Bernasconi S; Samanin R
    Pharmacol Res Commun; 1980 Mar; 12(3):215-23. PubMed ID: 7190307
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of chronic haloperidol and quinacrine coadministration on striatal HVA levels and stereotypic behaviors in response to apomorphine in the rat.
    Deutsch SI; Halperin R; Stanley M; Davis KL
    Neurochem Res; 1985 Apr; 10(4):491-8. PubMed ID: 2582289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apomorphine- and haloperidol-induced change in 3,4-dihydroxyphenylacetic acid content in the mesolimbic-striatum of the developing rat.
    Nomura Y; Oki K; Segawa T
    J Pharmacobiodyn; 1980 Feb; 3(2):111-6. PubMed ID: 7205536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spontaneous and drug-induced changes of cerebral dopamine turnover during postnatal development of rats.
    Keller HH; Bartholini G; Pletscher A
    Brain Res; 1973 Dec; 64():371-8. PubMed ID: 4781347
    [No Abstract]   [Full Text] [Related]  

  • 9. Differential effects of acute and chronic administration of haloperidol on homovanillic acid levels in discrete dopaminergic areas of rat brain.
    Matsumoto T; Uchimura H; Hirano M; Kim JS; Yokoo H; Shimomura M; Nakahara T; Inoue K; Oomagari K
    Eur J Pharmacol; 1983 Apr; 89(1-2):27-33. PubMed ID: 6861888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Metabolism of dopamine and norepinephrine in rat brain after acute and chronic administration of haloperidol, loxapine and clozapine].
    Bürki HR
    Arzneimittelforschung; 1974 Jul; 24(7):983-4. PubMed ID: 4136404
    [No Abstract]   [Full Text] [Related]  

  • 11. Apomorphine antagonism of the elevation of homovanillic acid induced by antipsychotic drugs.
    Lahti RA; McAllister B; Wozniak J
    Life Sci I; 1972 Jul; 11(13):605-13. PubMed ID: 4347984
    [No Abstract]   [Full Text] [Related]  

  • 12. Enhancement of haloperidol-induced increase in rat striatal or mesolimbic 3,4-dihydroxyphenylacetic acid and homovanillic acid by pretreatment with chronic methamphetamine.
    Toru M; Mataga N; Takashima M; Nishikawa T
    Psychopharmacology (Berl); 1981; 74(4):316-20. PubMed ID: 6794073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition by apomorphine of the metoclopramide-induced catalepsy and increase in striatal homovanillic acid content.
    Ahtee L
    Br J Pharmacol; 1975 Nov; 55(3):381-5. PubMed ID: 1239323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The enhancement of the hypomotility induced by small doses of haloperidol in the phase of dopaminergic supersensitivity in mice.
    Masuda Y; Murai S; Saito H; Abe E; Fujiwara H; Kohori I; Itoh T
    Neuropharmacology; 1991 Jan; 30(1):35-40. PubMed ID: 2046878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apomorphine-haloperidol interactions: different types of antagonism in cortical and subcortical brain regions.
    Bacopoulos NG; Roth RH
    Brain Res; 1981 Feb; 205(2):313-9. PubMed ID: 7470869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Supersensitivity of spinal dopaminergic receptors in rat after chronic haloperidol.
    Maitra KK; Seth P; Mohanakumar KP; Ganguly DK
    Brain Res Bull; 1992 Jan; 28(1):133-5. PubMed ID: 1540840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tolerance to fluphenazine and supersensitivity to apomorphine in central dopaminergic systems after chronic fluphenazine decanoate treatment.
    Wheeler SC; Roth RH
    Naunyn Schmiedebergs Arch Pharmacol; 1980 Jun; 312(2):151-9. PubMed ID: 7190650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A simple, sensitive method for measuring 3,4-dihydroxyphenylacetic acid and homovanillic acid in rat brain tissue using high-performance liquid chromatography with electrochemical detection.
    Hefti F
    Life Sci; 1979 Aug; 25(9):775-81. PubMed ID: 491856
    [No Abstract]   [Full Text] [Related]  

  • 19. Inhibition by apomorphine of dopamine deamination in the rat brain.
    Di Chiara G; Balakleevsky A; Porceddu ML; Tagliamonte A; Gessa GL
    J Neurochem; 1974 Dec; 23(6):1105-8. PubMed ID: 4452897
    [No Abstract]   [Full Text] [Related]  

  • 20. Increased concentration of homovanillic acid in the brains of infant rabbits after administration of haloperidol to their nursing mothers.
    Lundborg P; Roos BE
    J Pharm Pharmacol; 1974 Oct; 26(10):816-8. PubMed ID: 4156541
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.